Overview

Actinic Keratoses Treatment With Metvix® in Combination With Light

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Limoges
Collaborators:
Galderma
Galderma R&D
Treatments:
Methyl 5-aminolevulinate